Results 121 to 130 of about 296,123 (303)

A Registry-Based Cohort Study of Pulmonary Tuberculosis Treatment Outcomes in Istanbul, Turkey

open access: yes, 2013
The aim of this study is to evaluate the treatment outcomes and identify factors associated with adverse tuberculosis treatment outcomes for bacteriologically confirmed pulmonary tuberculosis.
MCCURDY, Stephen A.   +6 more
core   +1 more source

Thoracic Diseases: Technique and Applications of Dual-Energy CT. [PDF]

open access: yesDiagnostics (Basel), 2023
Perrella A   +4 more
europepmc   +1 more source

Could it Be Diagnosed Earlier? A Retrospective Analysis of Lung Cancer

open access: yesEurasian Journal of Medicine
Background: Early diagnosis is one of the most critical factors influencing the prognosis of lung cancer. This study aims to investigate radiological diagnostic delays and their underlying causes in lung cancer.
Fatma Tokgöz Akyıl   +7 more
doaj   +1 more source

Cuproptosis and Mitophagy Mediated by the THUMPD1/IGF2R‐Dependent Suppression of AKT and Activation of AMPK Signaling Suppress Lung Adenocarcinoma Progression

open access: yesAdvanced Science, EarlyView.
THUMPD1 drives a tumor‐suppressive signaling cascade in lung adenocarcinoma by promoting IGF2R expression. IGF2R associates with PPP2R1A to suppress AKT and activate AMPK, leading to SLC31A1 upregulation and copper accumulation. Elevated copper disrupts mitochondrial metabolism and induces excessive mitophagy, thereby restraining tumor growth and ...
Kai Wu   +10 more
wiley   +1 more source

Applications of Robotic Surgery in Thoracic Diseases. [PDF]

open access: yesJ Clin Med, 2022
Casiraghi M, Mariolo AV, Spaggiari L.
europepmc   +1 more source

Pharmacologic Modulation of ARID3A with Rimegepant Reactivates Type I Interferon Signaling and Sensitizes Triple‐Negative Breast Cancer to PD‐1 Blockade

open access: yesAdvanced Science, EarlyView.
This study identifies ARID3A as a key immunosuppressive transcription factor in TNBC. Its inhibition activates the type I IFN pathway, boosting CD8+ T cell infiltration and sensitizing tumors to anti‐PD‐1. The FDA‐approved migraine drug Rimegepant targets ARID3A, enhances immunotherapy efficacy in preclinical models, and establishes a druggable axis to
Teng Zhou   +12 more
wiley   +1 more source

Controlling Tuberculosis in the United States: Recommendations From the American Thoracic Society, CDC, and the Infectious Diseases Society of America [PDF]

open access: yes
During 1993-2003, incidence of tuberculosis (TB) in the United States decreased 44% and is now occurring at a historic low level (14,874 cases in 2003).

core  

Approach to the athlete with thoracic aortic disease

open access: yesCurrent Sports Medicine Reports, 2007
Sports medicine specialists have a unique opportunity to identify individuals who may be at risk for thoracic aortic disease. These patients may have physical features such as tall stature and long limbs (which typify Marfan syndrome), but also lend themselves to participation in competitive athletics.
Ibrahim M, Saeed, Alan C, Braverman
openaire   +3 more sources

Ultrasound‐Activated Bifunctional Piezoelectric Hydrogel Dressings Promote Infected Wound Healing via Regulating Angiogenesis and Lymphangiogenesis

open access: yesAdvanced Science, EarlyView.
This study developed a double‐network hydrogel with piezoelectric properties, exhibiting excellent antibacterial activity and promoting fibroblast migration, angiogenesis, and lymphangiogenesis through piezoelectric stimulation, thereby accelerating the healing of infected chronic wounds.
Xiang Li   +7 more
wiley   +1 more source

Women and non communicable diseases (chronic conditions) [PDF]

open access: yes, 2014
Non-communicable diseases (cancer, cardiovascular disease, diabetes, chronic respiratory conditions, and musculo-skeletal conditions) are the number one cause of death and disablement for women and men globally and in Australia, with increasing ...

core  

Home - About - Disclaimer - Privacy